Teva Pharmaceutical Industries
is exploring strategic options for its animal-health business and might consider shedding the division.
Teva has retained Bear Stearns as its financial adviser to assist it in the review.
Shares of Israel-based Teva were down 1.6% at $47.21 Monday.
This article was written by a staff member of TheStreet.com.